Drug sponsors can now request a flexible service through our Scientific Advice program that can include a shorter time frame.
For Scientific Advice ...
Canada’s Drug Agency has released new guidance around aging in place. This guidance is intended to help health systems address Canada’s demographic ...
Today’s the day: we are officially Canada’s Drug Agency.
We are expanding on our existing mandate and functions — which span drugs, medical devices ...
Canada’s Drug Agency has published a national inventory of rare disease registries (RDRs) that includes both registries in Canada and international ...
Canada’s Drug Agency is pleased to announce the recipients of our 2024 Recognition Awards. These awards honour individuals who are pushing the science ...
A new Environmental Scan from Canada’s Drug Agency examines Canadian data related to alternate level of care (ALC) and the effectiveness of strategies ...
Symposium 2024 is a 3-day hybrid event that gathers leaders from across Canada with expertise in policy, industry, health technology assessment, patient advocacy, medicine, public health, and communications. The theme of Symposium 2024 is From Disruption to Opportunity: Embracing Change in Health Care.